Electra Therapeutics, Inc. ETRA
8.84 USD -0.27 (-2.96%)
At closeNov 13, 2026, 7:30 PM EST
9.05 +0.21 +2.38%
After hours · Nov 13, 7:30 PM ET
7.62 Day range 9.37
7.31 52-week range 13.92
- YTD
- -33.28%
- 1 year
- -33.28%
- Market cap
- 554.86M
- EPS (ttm)
- -2.65
- YTD return
- -33.28%
- 1-year return
- -33.28%
- Volume
- 313.15K
- Avg volume
- 589.34K
- Open
- 9.37
- Previous close
- 9.11
- Day's range
- 7.62 – 9.37
- 52-week range
- 7.31 – 13.92
5D +0.08 (+1.01%)
Financials — quick view
ETRA Revenue — annual 0
ETRA Net income — annual -61.98M
ETRA EPS — annual -1,408.52
News
Electra Therapeutics Q3 EPS $(3.47) Misses $(2.72) Estimate 
Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights 
Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Orbimed Advisors Llc Buys 245,113 Shares 
Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Carl Gordon Purchases 245,113 Shares 
Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Carl Gordon Purchases 245,113 Shares 
Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Orbimed Advisors Llc Buys 245,113 Shares 
This FirstEnergy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - HC Wainwright & Co. Initiates Coverage On Electra Therapeutics with Buy Rating, Announces Price Target of $30
12 Health Care Stocks Moving In Friday's Pre-Market Session 
Star Therapeutics Announces $200M Private Financing To Support Its Pipeline Of Potential Best-in-Disease Therapies
Your note
Sign in to keep a note on ETRA — it syncs with the Stock Master app.